Signaturefd, LLC Innoviva, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 3,954 shares of INVA stock, worth $70,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,954

Previous 3,954 -0.0%

Holding current value

$70,302

Previous $64,000 18.75%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$14.4 - $16.4 $43 - $49	3 Added 0.08%	3,954 $64,000
Q1 2024 May 03, 2024	SELL	$14.56 - $16.78 $1,557 - $1,795	-107 Reduced 2.64%	3,951 $60,000
Q4 2023 Jan 31, 2024	BUY	$12.32 - $16.27 $3,535 - $4,669	287 Added 7.61%	4,058 $65,000
Q3 2023 Nov 03, 2023	SELL	$12.37 - $13.89 $4,292 - $4,819	-347 Reduced 8.43%	3,771 $48,000
Q2 2023 Aug 01, 2023	BUY	$11.39 - $13.72 $15,820 - $19,057	1,389 Added 50.9%	4,118 $52,000
Q1 2023 Apr 28, 2023	BUY	$10.73 - $13.6 $26,546 - $33,646	2,474 Added 970.2%	2,729 $30,000
Q3 2022 Nov 08, 2022	BUY	$11.61 - $15.22 $2,542 - $3,333	219 Added 608.33%	255 $3,000
Q1 2022 May 02, 2022	SELL	$15.39 - $20.25 $2,739 - $3,604	-178 Reduced 83.18%	36 $1,000
Q4 2021 Jan 25, 2022	BUY	$15.91 - $18.72 $2,259 - $2,658	142 Added 197.22%	214 $4,000
Q3 2021 Oct 28, 2021	BUY	$13.06 - $17.24 $470 - $620	36 Added 100.0%	72 $1,000
Q2 2021 Jul 26, 2021	BUY	$11.45 - $13.96 $412 - $502	36 New	36 $0
Q4 2020 Feb 11, 2021	SELL	$9.33 - $12.48 $1,306 - $1,747	-140 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$10.33 - $14.49 $1,446 - $2,028	140 New	140 $1,000
Q3 2018 Nov 15, 2018	SELL	$13.63 - $15.7 $9,541 - $10,990	-700 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $9,408 - $12,313	700 New	700 $10,000

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account